JP2017514875A5 - - Google Patents

Download PDF

Info

Publication number
JP2017514875A5
JP2017514875A5 JP2016566943A JP2016566943A JP2017514875A5 JP 2017514875 A5 JP2017514875 A5 JP 2017514875A5 JP 2016566943 A JP2016566943 A JP 2016566943A JP 2016566943 A JP2016566943 A JP 2016566943A JP 2017514875 A5 JP2017514875 A5 JP 2017514875A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
sphincter
composition according
sdf
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016566943A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017514875A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/028490 external-priority patent/WO2015171417A1/en
Publication of JP2017514875A publication Critical patent/JP2017514875A/ja
Publication of JP2017514875A5 publication Critical patent/JP2017514875A5/ja
Pending legal-status Critical Current

Links

JP2016566943A 2014-05-08 2015-04-30 失禁および他の括約筋不全障害を処置する方法 Pending JP2017514875A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461990190P 2014-05-08 2014-05-08
US61/990,190 2014-05-08
PCT/US2015/028490 WO2015171417A1 (en) 2014-05-08 2015-04-30 Methods of treating incontinence and other sphincter deficiency disorders

Publications (2)

Publication Number Publication Date
JP2017514875A JP2017514875A (ja) 2017-06-08
JP2017514875A5 true JP2017514875A5 (cg-RX-API-DMAC7.html) 2018-06-14

Family

ID=54392862

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016566943A Pending JP2017514875A (ja) 2014-05-08 2015-04-30 失禁および他の括約筋不全障害を処置する方法

Country Status (6)

Country Link
US (2) US10420818B2 (cg-RX-API-DMAC7.html)
EP (1) EP3139945B1 (cg-RX-API-DMAC7.html)
JP (1) JP2017514875A (cg-RX-API-DMAC7.html)
AU (1) AU2015256383B2 (cg-RX-API-DMAC7.html)
CA (1) CA2946761C (cg-RX-API-DMAC7.html)
WO (1) WO2015171417A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015171417A1 (en) 2014-05-08 2015-11-12 Wake Forest University Health Sciences Methods of treating incontinence and other sphincter deficiency disorders
CA3055761A1 (en) 2017-03-30 2018-10-04 Wake Forest University Health Sciences Methods of treatment for kidney disease
WO2019032930A1 (en) * 2017-08-11 2019-02-14 Wake Forest University Health Sciences USE OF CXCL12 FOR THERAPY AFTER SURGERY OF THE PROSTATE
CN114159471A (zh) * 2020-09-11 2022-03-11 永立荣生医股份有限公司 包括羊水干细胞球的医药组合物及其治疗尿失禁的用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US311219A (en) 1885-01-27 Mechanical toy
JP2609851B2 (ja) 1986-09-04 1997-05-14 悦子 柿崎 徐放性注射剤
US5385561A (en) 1994-01-18 1995-01-31 Bard International, Inc. Apparatus and method for injecting a viscous material into the tissue of a patient
DE4414755C2 (de) * 1994-04-27 2000-11-16 Lohmann Therapie Syst Lts Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
US5588960A (en) 1994-12-01 1996-12-31 Vidamed, Inc. Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence
US5925629A (en) 1997-10-28 1999-07-20 Vivus, Incorporated Transurethral administration of androgenic agents for the treatment of erectile dysfunction
WO2001094420A1 (en) 2000-06-05 2001-12-13 The Trustees Of Columbia University In The City Of New York Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
AU2002322493A1 (en) 2001-07-10 2003-01-29 Ams Research Corporation Surgical kit for treating prostate tissue
KR20070085288A (ko) 2004-09-24 2007-08-27 안지오블라스트 시스템스 인코퍼레이티드 간엽 전구세포의 증식 및/또는 생존성 증강 방법
WO2007035843A2 (en) * 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
US7939057B2 (en) 2006-01-25 2011-05-10 Mount Sinai School Of Medicine Methods and compositions for modulating the mobilization of stem cells
US7598028B2 (en) 2006-11-28 2009-10-06 The Regents Of The University Of Michigan Compositions and methods for detecting and treating prostate disorders
CA2691361A1 (en) * 2007-06-15 2008-12-24 Ethicon, Inc. Tissue fragment compositions for the treatment of incontinence
ATE543507T1 (de) 2007-11-07 2012-02-15 Ono Pharmaceutical Co Sdf-1 enthaltende zusammensetzung mit anhaltender freisetzung
WO2009079451A2 (en) * 2007-12-14 2009-06-25 The Cleveland Clinic Foundation Compositions and methods of promoting wound healing
WO2010019507A2 (en) 2008-08-09 2010-02-18 Massachusetts Institute Of Technology Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues
AU2010286511B2 (en) 2009-08-28 2016-05-26 Juventas Therapeutics, Inc. SDF-1 delivery for treating ischemic tissue
US9308277B2 (en) * 2010-02-25 2016-04-12 Mesoblast International Sàrl Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
WO2015171417A1 (en) 2014-05-08 2015-11-12 Wake Forest University Health Sciences Methods of treating incontinence and other sphincter deficiency disorders

Similar Documents

Publication Publication Date Title
das Neves et al. Polymer-based nanocarriers for vaginal drug delivery
Zhang et al. Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
JP2015518818A5 (cg-RX-API-DMAC7.html)
MY188825A (en) High-concentration monoclonal antibody formulations
JP2017514875A5 (cg-RX-API-DMAC7.html)
AU2016204185A1 (en) Methods of administering beta7 integrin antagonists
JP2015510928A5 (cg-RX-API-DMAC7.html)
JP2012517478A5 (cg-RX-API-DMAC7.html)
HRP20200704T1 (hr) Vodena formulacija koja sadrži paracetamol i ibuprofen
JP2016515586A5 (cg-RX-API-DMAC7.html)
JP2020520368A5 (cg-RX-API-DMAC7.html)
JP2019521101A5 (cg-RX-API-DMAC7.html)
FI3359572T3 (fi) Menetelmä multippeliskleroosin hoitamiseksi
JP2010510218A5 (cg-RX-API-DMAC7.html)
NZ727292A (en) Methods of treating incontinence and other sphincter deficiency disorders
Bang et al. A case of psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease
CN106421796A (zh) 索拉菲尼联合ccr4拮抗剂在抑制癌生长及转移中的应用
Yu et al. Injectable thermogels and their biomedical applications
Kempeneers Isotretinoin/minocycline
Jeon et al. Renoprotective effect of gemigliptin in UUO model via regulating inflammasome
Kim et al. Efficacy of intralesional immunotherapy using the measles, mumps and rubella vaccine in children with molluscum contagiosum
Lee et al. PS 0839; Upper GI Tract: Clinical Characteristics of Non-Variceal Upper Gastrointestinal Bleeding in the Elderly
Choi et al. Acute localized exanthematous pustulosis: secondary to amoxicillin/clavulanate
Kim et al. PS 0873; Lower GI Tract: A Comparison Between 2l Ascorbic Acid Mixed Peg and Combination of 1l Ascorbic Acid Mixed Peg and Bisacodyl
Kim et al. Open Access: Learning Curve of Capsule Endoscopy